2007 - 2008 Involvement of DNA repair protein REV7 in cell proliferation, mobility and organogenesis
2006 - 2007 Sprouty family of proteins regulates organogenesis and carcinogenesis through the signaling caused by RET tyrosine kinase
2005 - 2006 Generation and Characterization of Knockout Mice Targeting REV7 gene, which is involved in DNA damage tolerance
2003 - 2006 In vivo role of the GDNF/RET signaling pathway in morphogenesis and pathogenesis
2002 - 2003 Characterization of human REV proteins which are involved in mutagenesis
2002 - 2003 Glial Cell line-derived neurotrophic factor (GDNF) inducible genes regulate neuronal differentiation and kidney development
1996 - DNA損傷と発癌
1996 - DNA damage and carcinogenesis
DNA修復と突然変異
DNA repair and mutagenesis
Show all
Papers (145):
Akihiro Tamaki, Takuya Kato, Yasutaka Sakurai, Keita Sato, Kai Adachi, Masayoshi Tadehara, Taro Kogami, Masahiro Matsushita, Akiyoshi Hoshino, Itaru Sanoyama, et al. REV7 is involved in outcomes of platinum-based chemotherapy in pancreatic cancer by controlling the DNA damage response. Cancer science. 2024. 115. 2. 660-671
Kazu Shiomi, Masaaki Ichinoe, Ai Ushiwata, Koji Eshima, Ryo Nagashio, Shoko Hayashi, Dai Sonoda, Yasuto Kondo, Raito Maruyama, Masashi Mikubo, et al. Insight into the significance of CD8+ tumor-infiltrating lymphocytes in squamous cell lung cancer. Thoracic Cancer. 2023
Yuko Shimada, Takuya Kato, Yasutaka Sakurai, Hitoe Watanabe, Mayu Nonaka, Natsumi Nanaura, Masaaki Ichinoe, Yoshiki Murakumo. Identification of the promoter region regulating the transcription of the REV7 gene. Biochemical and biophysical research communications. 2023. 662. 8-17
Yoshiki Murakumo, Yasutaka Sakurai, Takuya Kato, Hiroshi Hashimoto, Masaaki Ichinoe. REV7 in Cancer Biology and Management. Cancers. 2023. 15. 6
Shotaro Tatekawa, Keisuke Tamari, Ryota Chijimatsu, Masamitsu Konno, Daisuke Motooka, Suguru Mitsufuji, Hirofumi Akita, Shogo Kobayashi, Yoshiki Murakumo, Yuichiro Doki, et al. N(6)-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis as a potential target of radiotherapy in pancreatic adenocarcinoma. Scientific Reports. 2022. 12. 1
Shinji Mii, Yoshiki Murakumo, Naoya Asai, Masato Asai, Masahide Takahashi. Deficiency of CD109, a negative regulator of TGF-beta signaling, leads epidermal hyperplasia and appendage abnormalities in mice. CANCER RESEARCH. 2012. 72
Yoshiki Murakumo, Masahide Takahashi. Glycosylation-dependent effect of CD109 on TGF-beta1 and EGF signaling in human glioblastoma cells. CANCER RESEARCH. 2012. 72
- 1995 Nagoya University Graduate School, Division of Medicine Depertment of Pathology
- 1988 Nara Medical University
- 1988 Nara Medical University Devision of Medicine
Professional career (1):
Doctor of Medicine (Nagoya University)
Work history (9):
2006 - 2012 - 名古屋大学大学院医学系研究科病理病態学講座准教授
2002 - 2006 名古屋大学大学院医学系研究科病理病態学講座講師
2000 - 2002 名古屋大学大学院医学系研究科病理病態学講座助手
2000 - 2002 Assistant Professor, Department of Pathology, Nagoya University Graduate School of Medicine
1995 - 1996 名古屋記念病院腫瘍科医師
1995 - 1996 Oncology, Nagoya Menorial Hospital
1989 - 1991 名古屋記念病院内科医師
1989 - 1991 Internal medicine, Nagoya Memorial Hospital
Nagoya University Graduate School of Medicine, Function Construction Medicine, Graduate School of Medicine Funtion Construction Medicine Associate Professor
Show all
Committee career (1):
2001 - 日本病理学会 評議員
Association Membership(s) (8):
日本臨床細胞学会
, 日本病理学会
, 日本癌学会
, アメリカ癌学会
, Japanese Society of Clinical Cytology
, Japanese Sociaty of Pathology
, Japanese Cancer Association
, American Association for Cancer Research